funding

Galimedix's oral Alzheimer's candidate clears ph. 1 safety test

The small molecule caused no serious adverse events and successfully crossed the blood-brain barrier in a trial with more than 100 healthy volunteers.

Darren Incorvaia Sep 12, 2025 11:11am

Massachusetts Massachusetts flag MA MA flag

Fierce Pharma

Massachusetts shed R&D, manufacturing workers in '24: report

Aug 27, 2025 9:34am

HHS axes Moderna's $590M pandemic bird flu vaccine contract

May 29, 2025 4:30am

A series of dice with a bag on them illustrating cost cuts

Eikon blames US cuts for 15% staff reduction

May 22, 2025 7:55am

NIH terminated $1.8B in grants in 40 days under Trump: study

May 9, 2025 3:04am

Concept of loss of money downward arrow made of dollar banknotes on white background

'Too big and unfocused': Trump slashes NIH budget by $18B

May 2, 2025 2:42pm